Daniella KranjacFounding General Partner at Avant BioSpeaker
Profile
With 25 years of experience in the life sciences industry, I am proud to have founded Avant Bio LLC, an early stage and growth equity firm focused on investing in and building transformative therapeutic-enabling technologies. I have a strong background in strategy, commercialization, and leadership, with an executive MBA from NYU Stern, and undergraduate degree from Stevens Institute of Technology.
I have a passion for supporting life science entrepreneurs with highly disruptive, market-defining technologies, and helping them realize their full potential. I have also contributed to the advancement of the field through thought leadership, articles and awards, such as the Technology of the Decade for the WAVE Bioreactor, an early disruptive technology in single-use manufacturing. I am driven by the mission of creating positive impact on human health and society through innovation.
Agenda Sessions
What is TechBio and What Impact Will It Have on Therapeutic Development?
, 14:30View Session